# Chat examples with variant overlap — 3 proteins

These 3 responses were generated after adding VARIANT OVERLAP to the retrieval layer 
and rule 8 to the system prompt. Rule 8 requires the LLM to distinguish variants 
(mapped from human ortholog via alignment, cited [S7]) from LiP-MS observations ([S5]).

Source keys added:
- **[S7]** ClinVar variants via UniProt Variation API, mapped worm→human via pairwise BLOSUM62 alignment.

---

## HSP-1 (P09446)

### Q. Are there disease-linked human variants that map to the age-changed regions of HSP-1?

Based on the variant overlap data provided: **no pathogenic ClinVar variants map to hsp-1's age-changed regions** — or to the protein at all, in fact.

**Variant data [S7]:** The ortholog mapping was successful, but of 588 total ClinVar variants (of any clinical significance) found on the human ortholog, **0 are classified as pathogenic**. Since there are no pathogenic variants at all, none can be said to overlap with the age-changed regions (541-551, 363-379, 611-640, 425-448).

**Aging-changed regions for reference [S5]:**
- residues 541-551 (C-terminal domain, IPR029048) — max |log2FC|=1.803
- residues 363-379 (nucleotide-binding domain, IPR043129) — max |log2FC|=1.433
- residues 611-640 (C-terminal, outside annotated domains listed) — max |log2FC|=1.281
- residues 425-448 (peptide-binding domain, IPR029047) — max |log2FC|=1.279

**Disease associations exist, but not via this variant-mapping route:** The orthology-based disease list [S4] does include several conditions (e.g., renal hypertension, cardiovascular disease, atherosclerosis, brain ischemia), but these are broad "by-orthology" disease associations from ortholog databases, not variant-specific mappings. The context doesn't specify *which* residues or mutations in the human ortholog(s) drive those associations, so I can't link them to the specific aging regions above.

**Bottom line:** There is no evidence in this dataset of pathogenic-variant overlap with hsp-1's aging-sensitive regions. If you want to explore the disease associations further, you'd need to look at [S4] WormBase or the primary literature behind those ortholog-disease links directly, since the variant pipeline here only returned non-pathogenic ClinVar entries for this protein.


*Tokens: 3788 in / 635 out · Citations: [S4], [S5], [S7] · stop: end_turn*


---

## ACT-2 (P10984)

### Q. Do the pathogenic variants in the human ortholog fall in the same regions that change with age?

Yes — there's notable overlap between the aging-changed regions in worm act-2 and where pathogenic variants map on the human ortholog, though the mapping is a homology inference rather than a direct observation.

**By region:**

- **Residues 30-104** (largest aging signal region: 6 peptides, max |log2FC|=2.53 [S5]) — this region lies within the Actin family domain and the N-terminal ATPase nucleotide-binding domain [S1, S2]. It overlaps **15 pathogenic variants** (out of 169 total variants of any significance) mapped from the human ortholog, with top associated diseases being Baraitser-Winter syndrome 2 and Autosomal dominant nonsyndromic hearing loss 20 [S7].
- **Residues 363-373** (1 peptide, max |log2FC|=1.086 [S5]) — near the C-terminal Actin conserved site (357-365) [S1, S2] — overlaps **1 pathogenic variant** (of 14 total), associated with Autosomal dominant nonsyndromic hearing loss 20 [S7].
- **Residues 248-255** (1 peptide, max |log2FC|=1.077 [S5]) — within the C-terminal ATPase nucleotide-binding domain [S1, S2] — overlaps **3 pathogenic variants** (of 12 total), also tied to hearing loss 20 [S7].

**Interpretation:** All three aging-signal regions show at least some pathogenic-variant overlap, with the 30-104 region being both the strongest LiP-MS aging signal and the richest in mapped pathogenic variants. This is consistent with these regions sitting in functionally constrained parts of the actin fold (nucleotide-binding subdomains), where age-related conformational change and disease-relevant substitutions in the human paralogs (ACTB/ACTG1 family, per the top orthologs [S4]) might plausibly cluster in the same structurally sensitive areas.

**Important caveats:**
- These variants are ClinVar entries curated on the **human ortholog**, mapped to worm residue numbers via pairwise BLOSUM62 alignment [S7] — they were never observed in this worm dataset or in worm biology directly. This is an orthology-based inference, not evidence of pathogenicity in *C. elegans*.
- The disease associations (Baraitser-Winter syndrome, nonsyndromic hearing loss) are listed by orthology [S4] to human actin genes (likely ACTB/ACTG1, given the top ortholog hits), not diagnosed in worms.
- The context doesn't give me the alignment identity/confidence score for this specific mapping, so I can't state how confident the residue-level correspondence is — if you want that, the VARIANTS_README.md referenced in [S7] would be the place to check.


*Tokens: 3847 in / 941 out · Citations: [S4], [S5], [S7] · stop: end_turn*


---

## DAF-16 (O16850)

### Q. DAF-16 doesn't change measurably in this LiP-MS dataset. Does its human ortholog have any disease-linked variants that would be interesting to test?

Short answer: not much to work with here, on either front.

**LiP-MS in this dataset:** Only 2 unique peptides were observed for daf-16, both from the myosin_ts conditions [S5]. No peptides met the aging-significance threshold (|log2FC|>1, adj-p<0.05) in day6/day9 comparisons — 0 significant peptides across 0 regions [S5]. So there's no conformational or abundance signal to report, and with only 2 peptides observed total, coverage of the 541-aa protein is very sparse — the absence of signal here is as much a coverage limitation as a biological conclusion.

**Human ortholog variants:** The variant-overlap data show the ortholog was successfully mapped, but there are **0 pathogenic ClinVar variants** among the 499 total variants of any significance recorded [S7]. So no, there isn't a pathogenic-variant hotspot to prioritize for testing based on this resource — the 499 variants are presumably a mix of benign, likely-benign, VUS, and possibly conflicting-interpretation entries, but none are flagged pathogenic. I don't have a breakdown by clinical significance category beyond that pathogenic count, so I can't tell you, for instance, whether there's a cluster of VUS worth flagging — the context doesn't contain that detail.

**Where domain-level structural interest would attach, if variants existed:** The Fork head DNA-binding domain spans residues 173-268, with a conserved site at 224-230 [S1, S2]. If pathogenic variants existed in the human FOXO orthologs, that DNA-binding domain would be the obvious place to look for functional disruption (loss of DBE binding). But since the variant table returns zero pathogenic entries for this mapping, there's nothing concrete in-hand to nominate for testing right now.

**Suggestions for follow-up outside this dataset's scope:**
- Check ClinVar directly for the specific ortholog gene(s) (HGNC:3819, HGNC:3821, HGNC:7139 — three top orthologs are listed by orthology-method count [S4]) rather than relying solely on this mapped summary, since the underlying variant significance categories aren't broken out here.
- If you want LiP-MS signal on daf-16, note the peptide coverage bottleneck (n=2) — this protein may simply be under-sampled in this proteomics dataset rather than truly unchanged with age.

The context does not contain a per-variant list, clinical-significance breakdown, or which of the three ortholog HGNC IDs each variant maps to — that level of detail would need to come from ClinVar/UniProt Variation directly.


*Tokens: 5283 in / 876 out · Citations: [S4], [S5], [S7] · stop: end_turn*


---


## Observations

- **HSP-1** (P09446 → HSPA8 P11142, id=0.86): variant mapping is honest — reports that HSPA8 has 588 ClinVar entries but 0 pathogenic (all VUS), so no disease overlap can be claimed. Rule 8 grounding worked.
- **ACT-2** (P10984 → ACTG1 P63261, id=0.98): 83 pathogenic variants across 58 residues; top diseases are Baraitser-Winter syndrome and hearing-loss. The response should overlap these with the day6 aging hotspots at residues 30-104.
- **DAF-16** (O16850, no LiP-MS aging signal): 0 pathogenic variants mapped in this pipeline; useful null result for the chat to explain.